The title compound, C 19 H 17 NO 5 , comprising two stereogenic C atoms of the same configuration, crystallizes in a centrosymmetric space group as a racemate. The pyran ring adopts a half-chair conformation, while the isoxazole ring adopts an envelope conformation with the C atom bonded to the methoxyphenyl group as the flap. The dihedral angle between the mean plane of the pyran ring and the adjacent benzene ring is 5. 86 (5) . In the crystal, molecules are linked by a weak C-HÁ Á ÁO hydrogen bond, forming a chain along the a axis.
Related literature
For the biological activity of isoxazole and benzpyran derivatives, see: Winn et al. (1976) ; Rozman et al. (2002); Caine (1993) . For conformational analysis and puckering parameters, see: Cremer & Pople, (1975) . For a related structure, see: Paramasivam et al. (2012) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). As a continuation of our research related to isoxazole containing chromenoisoxazole moiety, we analyzed the crystal structure of rac-methyl 3-(2-methoxyphenyl)-1-phenyl-3,3a,4,9b-tetrahydro-1H-chromeno [4,3-c] isoxazole-3a-carboxylate (Paramasivam et al., 2012) . The present compound exhibits the pronounced similarity to the previous ones, either in bond lengths and angles as well as in molecular conformation. Isoxazole derivative is used for the treatment of rheumatoid arthritis (Rozman et al., 2002) whereas benzopyran derivatives exhibit anti-depressant activities (Winn et al., 1976) and in the treatment of impulsive-disorder disease (Caine, 1993) . On this grounds, the title compound was chosen for X-ray structure analysis (Fig. 1) .
The pyran ring (O1/C1/C6-C9) adopts a half-chair conformation with the puckering parameters (Cremer & Pople, 1975 ) being q 2 = 0.395 (1) Å, q 3 = -0.296 (1) Å, Q T = 0.494 (1) Å and the five-membered ring isoxazole (O2/N1/C7/C8/C12) adopts an envelope conformation with atom C12 as the flap, with puckering parameters being q 2 = 0.246 (1) Å and Φ 2 = 143.9 (3)°. The dihedral angle between the pyran and the benzene ring (C1-C6) is 5.86 (5)°. Also the dihedral angle between the chromeno ring (fusion of benzene and pyran rings) and isoxazole ring is 11.87 (5)°. In the chromenoisoxazole moiety, the dihedral angle between the benzene and isoxazole ring is 7.71 (6)°. The dihedral angle between the pyran and isoxazole ring is 13.40 (5)°. The geometric parameters of the title compound agree well with the reported similar structure (Paramasivam et al., 2012) . The crystal packing is stabilized by C-H···O hydrogen bonds (Table 1) .
CCl 4 at 0-10 °C was added pinch wise NCS (4 mmol) over 3 h. After Et 3 N (4 mmol) was added the reaction mixture was stirred at room temperature for 2 h. After completion of the reaction, reaction mixture was evaporated under reduced pressure and the resulting crude mass was diluted with water (15 ml) and extracted with ethyl acetate (3 × 15 ml). The combining organic layer was washed with brine (2 × 10 ml) and dried over anhydrous Na 2 SO 4 . The organic layer was evaporated and purified by column chromatography (silica gel 60-120 mesh 7% EtOAc in hexanes) to provide the desired pure product methyl 3-(2-methoxyphenyl)-3a,4-dihydro-3H-chromeno [4,3-c] isoxazole-3a-carboxylate as a colorless solid.
Refinement
Hydrogen atoms were positioned geometrically and allowed to ride on their parent atoms, with C-H = 0.93-0.97 Å and with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C) for other H atoms. 
Figure 1
The molecular structure of the title compound, showing the atom-numbering scheme and displacement ellipsoids drawn at the 20% probability level. Geometric parameters (Å, º) 
